FibroBiologics is a publicly traded clinical-stage Biopharmaceutical company with 150 U.S. and international issued patents issued/pending, focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, certain cancers, and potential extension of life applications including thymic involut...
FibroBiologics is a publicly traded clinical-stage Biopharmaceutical company with 150 U.S. and international issued patents issued/pending, focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, certain cancers, and potential extension of life applications including thymic involut...
